fungemia การใช้

Fungemia : An Adverse Effect of " Saccharomyces boulardii"
An intravenous echinocandin such as caspofungin or micafungin is recommended as first-line therapy for fungemia, specifically candidemia.
Since the 2009 report, C . auris infections, specifically fungemia, have been reported from South Korea, India, South Africa, and Kuwait.
Fungemia is very common, often with deep organ involvement ( lung, liver, spleen, and central nervous system ) and also skin and mucous membranes lesions.
In children with lowered immune systems or who are already critically ill, consumption of probiotics may rarely cause bacteremia or fungemia, leading to sepsis, which is a potentially fatal disease.